Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
All Work
Chris Lange
Why Wedbush Is Bucking the Trend on Snap
Snap shares made a handy gain early Tuesday after one key analyst decided to upgrade the stock. Is this the signal for a long-awaited turnaround?
Sonos: Why Its First Public Quarter Doesn’t Sound Right
Why Sonos shares tumbled after the release of its fiscal third-quarter financial results.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a mixed day for the broad U.S. markets. Crude oil took a small step back in the session. The S&P 500 sectors were almost entirely positive.
What to Expect When Sonos Reports After the Close
Sonos is scheduled to release its fiscal third-quarter financial results after the markets close on Thursday.
Bank7 Announces Potential Pricing for IPO
Bank7 intends to price more than 3 million shares to result in an initial public offering valued up to more than $80 million.
Alibaba Sets Up Succession Plan for Jack Ma
Alibaba shares dipped on Monday after the Chinese e-commerce giant announced a succession plan for Founder and Executive Chair Jack Ma.
Why Fred’s Shares Are Skyrocketing
Fred’s shares exploded on Monday after the company announced a definitive asset purchase agreement with Walgreens Boots Alliance.
Snap’s Newest Change to Executive Leadership
Snap shares took a small step back on Monday after the company announced that there would be a change to its executive leadership team. The company’s chief strategy officer, Imran Khan, is leaving the…
Why Endocyte Shares Are Booming
Endocyte shares made a solid gain early on Monday after the company announced an update from the FDA.
Adobe, Kroger and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Adobe, Kroger and some of the other companies due to report their quarterly results this week.
Major Biopharma Catalysts on September’s FDA Calendar
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a down day for the broad U.S. markets, closing out what has been a terrible week for the Nasdaq (down about 2.5%). Crude oil traded sideways to close out the week. The…
Zekelman Industries Closes in on IPO
Steel producer Zekelman Industries intends to price more than 41 million shares to result in an initial public offering valued up to more than $912 million.
Is Tesla’s Future Up in Smoke?
Tesla shares tumbled on Friday after a couple of developments calling into question the company's executive leadership.
Dan Loeb and Third Point Launch Proxy Fight for Campbell Soup Board
Activist investor Dan Loeb and his firm Third Point, are looking to further take control of Campbell Soup and influence a sale, this time through the board of directors.
How Mattel Is Breaking Into Hollywood
Mattel shares were up handily on Friday after the firm announced that it would be launching a new theatrical film division to develop and produce motion pictures based on the Mattel’s iconic and globally…
How Palo Alto Networks Closed Out a Strong Q4
Palo Alto Networks reported better-than-expected fiscal fourth-quarter financial results after the markets closed on Thursday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a down day for the broad U.S. markets, continuing what has been a horrible week for the Nasdaq. Crude oil backed off again to fall further below $70. The S&P 500 sectors…
DocuSign Is Thursday’s Big Earnings Loser Despite a Solid Report
DocuSign shares retreated despite a report of better-than-expected fiscal second-quarter financial results.